Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.34
-0.14-5.65%
At close: -
$2.34
0.000.00%
After Hours: Jun 13, 7:58 PM EDT
Comments
Loading...
Microbot Medical Analyst Ratings and Price Targets | NASDAQ:MBOT | Benzinga
Microbot Medical Inc has a consensus price target of $9 based on the ratings of 1 analysts. The high is $9 issued by HC Wainwright & Co. on April 10, 2025. The low is $9 issued by HC Wainwright & Co. on April 10, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on April 10, 2025, January 24, 2025, and June 3, 2024, respectively. With an average price target of $8.33 between HC Wainwright & Co., there's an implied 256.13% upside for Microbot Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Microbot Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/10/2025 | Buy Now | 284.62% | HC Wainwright & Co. | Raghuram Selvaraju44% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 01/24/2025 | Buy Now | 284.62% | HC Wainwright & Co. | Raghuram Selvaraju44% | $7 → $9 | Maintains | Buy | Get Alert |
| 06/03/2024 | Buy Now | 199.15% | HC Wainwright & Co. | Raghuram Selvaraju44% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 04/16/2024 | Buy Now | 199.15% | HC Wainwright & Co. | Raghuram Selvaraju44% | $8 → $7 | Maintains | Buy | Get Alert |
| 10/18/2023 | Buy Now | 241.88% | HC Wainwright & Co. | Raghuram Selvaraju44% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2023 | Buy Now | 241.88% | HC Wainwright & Co. | Raghuram Selvaraju44% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | Buy Now | 241.88% | HC Wainwright & Co. | Raghuram Selvaraju44% | → $8 | Reiterates | → Buy | Get Alert |
| 05/09/2023 | Buy Now | 241.88% | HC Wainwright & Co. | Raghuram Selvaraju44% | $20 → $8 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Microbot Medical (MBOT) stock?
The latest price target for Microbot Medical (NASDAQ:MBOT) was reported by HC Wainwright & Co. on April 10, 2025. The analyst firm set a price target for $9.00 expecting MBOT to rise to within 12 months (a possible 284.62% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Microbot Medical (MBOT)?
The latest analyst rating for Microbot Medical (NASDAQ:MBOT) was provided by HC Wainwright & Co., and Microbot Medical reiterated their buy rating.
When was the last upgrade for Microbot Medical (MBOT)?
There is no last upgrade for Microbot Medical
When was the last downgrade for Microbot Medical (MBOT)?
There is no last downgrade for Microbot Medical.
When is the next analyst rating going to be posted or updated for Microbot Medical (MBOT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Microbot Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Microbot Medical was filed on April 10, 2025 so you should expect the next rating to be made available sometime around April 10, 2026.
Is the Analyst Rating Microbot Medical (MBOT) correct?
While ratings are subjective and will change, the latest Microbot Medical (MBOT) rating was a reiterated with a price target of $9.00 to $9.00. The current price Microbot Medical (MBOT) is trading at is $2.34, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
